Skip to main content
Veterinary Medicines

Systamex Vet. 3,75 g intraruminalinnlegg, periodevis frisetting

Authorised
  • Oxfendazole

Product identification

Medicine name:
Systamex Vet. 3,75 g intraruminalinnlegg, periodevis frisetting
Active substance:
  • Oxfendazole
Target species:
  • Cattle
Route of administration:
  • Intraruminal use

Product details

Active substance and strength:
  • Oxfendazole
    3.75
    gram(s)
    /
    5.00
    Tablet
Pharmaceutical form:
  • Continuous-release intraruminal device
Withdrawal period by route of administration:
  • Intraruminal use
    • Cattle
      • Meat and offal
        180
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC02
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 0000-07727
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."